Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Rydén

Showing results (1-10 of 266) with videos related to

Pageof 27
Sort By:
Nature Clinical Practice. Cardiovascular Medicine|May 15, 2008
What are the risk factors for progression of coronary artery calcification in patients with type 2 diabetes?Lars Rydén
Circulation|July 1, 2016
Response by Rydén to Letter Regarding Article, "Periodontitis Increases the Risk of a First Myocardial Infarction: A Report From the PAROKRANK Study"Lars Rydén
The Lancet. Diabetes & Endocrinology|December 3, 2021
Is the impact of add on heart failure therapy influenced by background therapy?Lars Rydén, Giulia Ferrannini
Journal of Internal Medicine|October 20, 2023
The 1923 Nobel Prize for the discovery of insulin in a 100-year perspectiveLars Rydén, Magnus Lindsten
The Lancet. Diabetes & Endocrinology|May 20, 2024
SGLT2 inhibitors in clinical practiceLars Rydén, Anna Norhammar
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|August 14, 2009
The political power of heart doctors: with the European Heart Health Charter towards a European policy on cardiovascular diseaseSophie O'Kelly, Lars Rydén
European Heart Journal|February 25, 2016
Treatment of diabetes and heart failure: joint forcesKarl Swedberg, Lars Rydén
Diabetes & Vascular Disease Research|July 4, 2012
Glucose perturbations and cardiovascular risk: challenges and opportunitiesLars Rydén, Linda Mellbin
Expert Review of Cardiovascular Therapy|October 27, 2012
Evidence for a beneficial effect of glucose-insulin-potassium in patients with acute coronary syndromes: Did the IMMEDIATE trial solve an unanswered question?Linda Mellbin, Lars Rydén
Diabetes Research and Clinical Practice|May 13, 2021
Heart failure at the crossroads of cardiology and diabetologyEberhard Standl, Lars Rydén
Pageof 27

Showing results (1-10 of 266) with videos related to

Sort By:
Pageof 27
Nature Clinical Practice. Cardiovascular Medicine|May 15, 2008
What are the risk factors for progression of coronary artery calcification in patients with type 2 diabetes?Lars Rydén
Circulation|July 1, 2016
Response by Rydén to Letter Regarding Article, "Periodontitis Increases the Risk of a First Myocardial Infarction: A Report From the PAROKRANK Study"Lars Rydén
The Lancet. Diabetes & Endocrinology|December 3, 2021
Is the impact of add on heart failure therapy influenced by background therapy?Lars Rydén, Giulia Ferrannini
Journal of Internal Medicine|October 20, 2023
The 1923 Nobel Prize for the discovery of insulin in a 100-year perspectiveLars Rydén, Magnus Lindsten
The Lancet. Diabetes & Endocrinology|May 20, 2024
SGLT2 inhibitors in clinical practiceLars Rydén, Anna Norhammar
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|August 14, 2009
The political power of heart doctors: with the European Heart Health Charter towards a European policy on cardiovascular diseaseSophie O'Kelly, Lars Rydén
European Heart Journal|February 25, 2016
Treatment of diabetes and heart failure: joint forcesKarl Swedberg, Lars Rydén
Diabetes & Vascular Disease Research|July 4, 2012
Glucose perturbations and cardiovascular risk: challenges and opportunitiesLars Rydén, Linda Mellbin
Expert Review of Cardiovascular Therapy|October 27, 2012
Evidence for a beneficial effect of glucose-insulin-potassium in patients with acute coronary syndromes: Did the IMMEDIATE trial solve an unanswered question?Linda Mellbin, Lars Rydén
Diabetes Research and Clinical Practice|May 13, 2021
Heart failure at the crossroads of cardiology and diabetologyEberhard Standl, Lars Rydén
Pageof 27